Ivacaftor is a pharmaceutical raw material used in the manufacturing of medications for cystic fibrosis. It is included in combination products alongside lumacaftor, tezacaftor, and elexacaftor for broader applicability in certain patient populations.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 873054-44-5
2,4-di-tert-Butyl-5-[(4-oxo-1,4-dihydroquinoline-3-carbonyl)amino]phenyl 4-oxo-1,4-dihydroquinoline-3-carboxylate
pharmaceutical intermediate
Ramipril
pharmaceutical raw material
Amtolmetin
pharmaceutical raw material
5-(1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)-N-[4-(trifluoromethyl)benzyl]pyridin-2-amine
pharmaceutical raw material
BMS-599626
pharmaceutical raw material
Deutivacaftor
pharmaceutical raw material
N-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide
PURKAOJPTOLRMP-UHFFFAOYSA-N
CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C